metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Detección de ADN de CMV en plasma mediante PCR en tiempo real utilizando SYBR-G...
Journal Information
Vol. 24. Issue 9.
Pages 541-545 (November 2006)
Share
Share
Download PDF
More article options
Vol. 24. Issue 9.
Pages 541-545 (November 2006)
Originales
Full text access
Detección de ADN de CMV en plasma mediante PCR en tiempo real utilizando SYBR-Green I como señal de amplificación
CMV DNA detection in plasma using real-time PCR based on the SYBR-Green I dye method
Visits
16917
Eduardo Varela-Ledoa,
Corresponding author
eduardo.varela.ledo@sergas.es

Correspondencia: Dr. E. Varela-Ledo. Hospital de Conxo. C.H.U.S. Ramón Baltar, s/n. 15706 Santiago de Compostela. A Coruña. España.
, Susana Romero-Yusteb, Patricia Ordóñez-Barbosaa, Patricia Romero-Junga, Elisabeth Prieto-Rodrígueza, Antonio Aguilera-Guiraoa, Benito Regueiro-Garcíaa
a Servicio de Microbiología. Complejo Hospitalario Universitario de Santiago de Compostela. España
b Servicio de Reumatología. Complejo Hospitalario de Pontevedra. España
This item has received
Article information
Objetivo

El objetivo del presente estudio es evaluar una técnica rápida y sencilla de reacción en cadena de la polimerasa (PCR) en tiempo real en LightCycler 2.0 revelada con SYBR-Green I, comparándola con otra técnica de PCR en tiempo real que utiliza sondas FRET (fluorescence resonance energy transfer) para revelar la amplificación.

Métodos

Los dos métodos de PCR en tiempo real se compararon utilizando muestras de plasma de pacientes inmunodeprimidos con sospecha clínica de enfermedad por citomegalovirus (CMV), de pacientes monitorizados sin sintomatología, y de adultos sanos. El estudio se completó con otras muestras de plasma congeladas de casos positivos por antigenemia pp65, y con ADN de CMV de la cepa Towne (ATCC VR-977) obtenido de cultivo en MRC-5, con el que elaboramos una curva estándar para su cuantificación.

Resultados

La PCR revelada con SYBR-Green I resultó ser claramente la más rentable por su alta sensibilidad, rapidez y sencilla realización, además de su bajo coste.

Conclusión

La determinación cuantitativa de ADN de CMV en plasma utilizando un método sensible, rápido y de bajo coste, como el que proponemos, supone una clara ventaja para el diagnóstico y seguimiento de estos cuadros, especialmente en hospitales como el nuestro, donde en los últimos años se ha incrementado sensiblemente el número de pacientes susceptibles de padecer esta infección oportunista.

Palabras clave:
Citomegalovirus
LightCycler
PCR en tiempo real
Objective

The aim of this study is to assess a real-time PCR technique on the LightCycler 2.0 with SYBR-Green I detection as compared to another real-time PCR method based on detection with FRET (fluorescence resonance energy transfer) probes for the quantification of CMV DNA.

Methods

The two real-time PCR methods were used to test plasma samples from immunocompromised patients with clinically suspected CMV disease, patients under follow-up without symptoms, and healthy adults. A standard curve for quantitative analysis by the SYBR-Green I method was performed with 10-fold diluted solutions of DNA from the CMV Towne strain (ATCC VR-977) cultured in MRC-5 monolayer. In addition, frozen samples from patients positive for CMV pp65 antigenemia were also analyzed and results compared using the two real time PCR methods.

Results

The real-time PCR technique using SYBR-Green I on the LightCycler 2.0 was a highly specific, fast, simple and reliable test to quantify CMV; moreover, it was cost-effective.

Conclusion

Quantification of CMV DNA in plasma using this sensitive, fast, low-cost method was advantageous for the diagnosis and follow up of patients with opportunistic CMV infection, which are increasingly more frequent in our daily hospital clinical practice.

Key words:
Cytomegalovirus
LightCycler
Real-time PCR
Full text is only aviable in PDF
Bibliografía
[1.]
A.M. Caliendo, Kirsten St. George, J. Allega, A.C. Bullota, L. Gilbane, C.R. Rinaldo.
Distinguishing Cytomegalovirus (CMV) Infection and Disease with CMV Nucleic Acid Assays.
J Clin Microbiol, 40 (2002), pp. 1591-1686
[2.]
R.L. Saltzman, M.R. Quirk, M.C. Jordan.
High levels of circulating Cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed Patients other than marrow recipients.
J Clin Invest, 90 (1992), pp. 1832-1838
[3.]
J.C. Meyers, P. Ljungman, L.D. Fisher.
Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia.
J Infect Dis, 162 (1990), pp. 373-380
[4.]
E.H.R. Haake, D. Weisdorf, N. Ramsay, P. McGlave, J. Kersey, W. Thomas, et al.
Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.
Transplantation, 55 (1993), pp. 1339-1346
[5.]
G.M. Schmidt, D.A. Hoak, J.C. Niland, S.R. Duncan, S.J. Forman, J.A. Zaia.
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogenic bone marrow transplants. The City of Hope-Stanford-Syntex CMV Study Group.
N Engl J Med, 324 (1991), pp. 1005-1111
[6.]
M. Falagas, D.R. Snydman, R. Ruthazer, B.G. Werner, J. Griffith, and The Boston Center for Liver Transplantation CMVIG Study Group.
Surveillance of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients.
Clin Infect Dis, 24 (1997), pp. 824-829
[7.]
J. Gerard, C. Leport, P. Flandre, N.D. Houhou, J.M. Salmon-Cer, P.C. Mandet, et al.
Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.
Clin Infect Dis, 24 (1997), pp. 836-840
[8.]
P.E. Wetherill, M.L. Landry, P. Alcabes, G. Friedland.
Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
J Acquired Immune Defic Syndr Hum Retrovirol, 12 (1996), pp. 33-37
[9.]
J. Zurlo, D. O’Neill, M.A. Polis, J. Manischewitz, R. Yarchoan, M. Baseler, et al.
Lack of clinical utility of cytomegalovirus blood and urine cultures with HIV infection.
Ann Intren Med, 118 (1993), pp. 12-17
[10.]
M. Boeckh, G. Hawkins, D. Myerson, J. Zaia, R.A. Bowden.
Plasma PCR for cytomegalovirus DNA after allogenic marrow transplantation: comparison with PCR using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Transplantation, 64 (1997), pp. 108-113
[11.]
A.M. Vlieger, G.J. Boland, N.M. Jiwa, R.A. De Weger, Willemze., G.C. De Gast, et al.
Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
Bone Marrow Transplant, 9 (1992), pp. 247-253
[12.]
J.M. Goodrich, M. Mori, C.A. Gleaves, C. Du Mond, M. Cays, D.F. Ebeling, et al.
Early treatment with ganciclovir to prevent cytomegalovirus diseases after allogeneic bone marrow transplant.
N Engl J Med, 325 (1991), pp. 1601-1607
[13.]
R.H. Rubin.
Preemptive therapy in immunocompromised hosts.
N Engl J Med, 324 (1991), pp. 1057-1059
[14.]
J.S. Kalpoe, A.C. Kroes, M.D. De Jong, J. Schinkel, C.S. De Brouwer, M.F. Beersma, et al.
Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection.
J Clin Microbiol, 42 (2004), pp. 1498-1504
[15.]
J. Ikewaki, E. Ohtsuka, R. Kawano, M. Ogata, H. Kikuchi, M. Nasu.
Real-Time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients.
J Clin Microbiol, 41 (2003), pp. 4382-4387
[16.]
S. Gouarin, A. Vabret, E. Gault, J. Petitjean, A. Regeasse, B. Hurault de Ligny, et al.
Quantitative analysis of HCMV DNA load in whole blood of renal patients using real-timebPCR assay.
J Clin Virol, 29 (2004), pp. 194-201
[17.]
S.E. Nesbitt, L. Cook, K.R. Jerome.
Cytomegalovirus quantitation by Real-Time PCR is unaffected by delayed separation of plasma from whole blood.
J Clin Microbiol, 42 (2004), pp. 1296-1297
[18.]
C.A. Foy, H.C. Parkes.
Emerging Homogeneous DNA-based Technologies in the Clinical Laboratory.
Clinical Chemistry, 47 (2001), pp. 990-1000
[19.]
M. Stöcher, V. Leb, M. Bozic, H.H. Kessler, G. Halwachs-Baumann, O. Landt, et al.
Parallel detection of human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run.
J Clin Virol, 26 (2003), pp. 85-93
[20.]
S. Lars, P. Kockelkorn, K. Ritter, M. Kleines.
Detection of CMV DNA in Human Specimens by LightCycler PCR.
J Clin Microbiol, 38 (2000), pp. 4006-4009
[21.]
H. Li, J.S. Dummer, W.R. Estes, S. Meng, P.F. Wright, T. Yi-Wei.
Measurement of Human Cytomegalovirus Loads by Quantitative Real-Time PCR for Monitoring Clinical Intervention in Transplant Recipients.
J Clin Microbiol, 41 (2003), pp. 187-191
[22.]
E.F. Bowen, C.A. Sabin, P. Wilson, P.D. Griffiths, C.C. Davey, M.A. Johnson, et al.
Cytomegalovirus viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.
Aids, 11 (1997), pp. 889-893
[23.]
G. Gerna, M. Furione, F. Baldanti, A. Sarasini.
Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.
J Clin Microbiol, 32 (1994), pp. 2709-2717
[24.]
T.H. The, M. Van der Ploeg, A.P. Van den Berg, A.M. Vlieger, M. Van der Giessen, W.J. Van Son.
Direct detection of cytomegalovirus in peripheral blood leukocytes – a review of the antigenemia assay and polymerase chain reaction.
Transplantation, 54 (1992), pp. 193-198
[25.]
J. Ikewaki, E. Ohtsuka, T. Satou, R. Kawano, M. Ogata, H. Kikuchi, et al.
Real-Time PCR assays based on distinct genomic regions for CMV reactivation following hematopoietic stem cell transplantation.
Bone Marrow Transplant, 35 (2005), pp. 403-410
[26.]
C. Aldea, C.P. Álvarez, L. Folgueira, R. Delgado, J.R. Otero.
Rapid detection of HSV DNA in Genital Ulcers by Real-Time PCR using SYBR-Green I Dye as the Detection Signal.
J Clin Microbiol, 40 (2002), pp. 1060-1062
[27.]
M. Stocher, J. Berg.
Normalized Quantification of Human Cytomegalovirus DNA by Competitive Real-Time PCR on the LightCycler Instrument.
J Clin Microbiol, 40 (2002), pp. 4547-4553
Copyright © 2006. Elsevier España S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos